Junyan Qian

917 total citations
40 papers, 418 citations indexed

About

Junyan Qian is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Oncology. According to data from OpenAlex, Junyan Qian has authored 40 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 14 papers in Rheumatology and 10 papers in Oncology. Recurrent topics in Junyan Qian's work include Pulmonary Hypertension Research and Treatments (17 papers), Systemic Lupus Erythematosus Research (10 papers) and Systemic Sclerosis and Related Diseases (7 papers). Junyan Qian is often cited by papers focused on Pulmonary Hypertension Research and Treatments (17 papers), Systemic Lupus Erythematosus Research (10 papers) and Systemic Sclerosis and Related Diseases (7 papers). Junyan Qian collaborates with scholars based in China, United States and Netherlands. Junyan Qian's co-authors include Jiuliang Zhao, Xiaofeng Zeng, Mengtao Li, Qian Wang, Zhuang Tian, Larry W. Kwak, Pei Lin, Yong Lu, Qing Yi and Yuhuan Zheng and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Junyan Qian

31 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junyan Qian China 12 126 125 123 105 90 40 418
Justyna Chwiećko Poland 13 98 0.8× 125 1.0× 93 0.8× 50 0.5× 287 3.2× 27 533
Hideki Makino Japan 11 96 0.8× 67 0.5× 74 0.6× 170 1.6× 73 0.8× 33 419
F. Moritz Germany 7 289 2.3× 136 1.1× 87 0.7× 39 0.4× 84 0.9× 16 519
Sanja Ivčević Croatia 13 187 1.5× 162 1.3× 127 1.0× 40 0.4× 95 1.1× 21 511
Xiangyang Huang China 12 117 0.9× 78 0.6× 41 0.3× 86 0.8× 106 1.2× 30 386
Fumihiro Kimura Japan 12 271 2.2× 92 0.7× 84 0.7× 82 0.8× 117 1.3× 39 628
Paola R. Lev Argentina 15 209 1.7× 143 1.1× 82 0.7× 72 0.7× 117 1.3× 32 676
Dorthe Vang Larsen Denmark 8 118 0.9× 44 0.4× 65 0.5× 62 0.6× 114 1.3× 8 483
Takayuki Katsuyama Japan 16 263 2.1× 308 2.5× 124 1.0× 94 0.9× 287 3.2× 47 792
Prasanna Kumar United States 12 186 1.5× 152 1.2× 244 2.0× 94 0.9× 15 0.2× 42 582

Countries citing papers authored by Junyan Qian

Since Specialization
Citations

This map shows the geographic impact of Junyan Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyan Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyan Qian more than expected).

Fields of papers citing papers by Junyan Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyan Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyan Qian. The network helps show where Junyan Qian may publish in the future.

Co-authorship network of co-authors of Junyan Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Junyan Qian. A scholar is included among the top collaborators of Junyan Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyan Qian. Junyan Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jiang, Hui, Yangzhong Zhou, Liying Peng, et al.. (2025). Impact of antiphospholipid antibodies on heart valve involvements in systemic lupus erythematosus: based on CSTAR cohort. Lupus Science & Medicine. 12(1). e001674–e001674.
3.
Wu, Wei, et al.. (2025). Double Trouble: Coronary Aneurysm and Löffler Endocarditis in Hypereosinophilic Syndrome. Circulation Heart Failure. 18(3). e012230–e012230.
4.
Qian, Junyan, Qian Wang, Zhuang Tian, et al.. (2025). Deciphering the transcriptomic landscape of systemic lupus erythematosus-associated pulmonary arterial hypertension. Respiratory Research. 26(1). 106–106.
5.
Qian, Junyan, Jinzhi Lai, Hui Wang, et al.. (2025). Predictive value of pulmonary to systemic vascular resistance ratio in systemic lupus erythematosus patients with pulmonary arterial hypertension. Journal of Hypertension. 43(6). 1042–1048.
6.
Hui, Min, Junyan Qian, Jiuliang Zhao, et al.. (2025). The association between STAT4 polymorphism and pulmonary arterial hypertension in Chinese patients with primary Sjögren’s syndrome. Clinical Rheumatology. 44(9). 3581–3590.
7.
Gao, Meiling, Junyan Qian, Ping Xia, et al.. (2025). Targeting the KLF5/PI3K/AKT axis as a therapeutic strategy to overcome neoadjuvant chemoresistance in colorectal cancer. Frontiers in Immunology. 16. 1593639–1593639.
8.
Qian, Junyan, Yangzhong Zhou, Shuang Zhou, et al.. (2024). Case report: Pulmonary artery hypertension secondary to SAPHO syndrome. International Journal of Rheumatic Diseases. 27(5). e15140–e15140. 1 indexed citations
9.
10.
Wu, Chanyuan, Peng Yin, Junyan Qian, et al.. (2024). Mortality-related health metrics in systemic autoimmune diseases: an epidemiological analysis of a nationwide register-based cohort. Science Bulletin. 70(4). 492–495. 3 indexed citations
11.
Wang, Jingqiao, Zhe Zhang, Junyan Qian, et al.. (2024). Clinical features of Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuritis associated with SLE. Lupus Science & Medicine. 11(2). e001244–e001244. 2 indexed citations
12.
Qian, Junyan, Xinzhuang Yang, Jiuliang Zhao, et al.. (2023). Association Study Identified HLA‐DQA1 as a Novel Genetic Risk of Systemic Lupus Erythematosus‐Associated Pulmonary Arterial Hypertension. Arthritis & Rheumatology. 75(12). 2207–2215. 8 indexed citations
13.
Qian, Junyan, Xiaoxi Yang, Qian Wang, et al.. (2023). The diagnostic and prognostic value of growth differentiation factor‐15 in systemic lupus erythematosus‐associated pulmonary arterial hypertension. Pulmonary Circulation. 13(1). e12195–e12195. 6 indexed citations
14.
Qian, Junyan, Shangzhu Zhang, Dong Xu, et al.. (2022). Immunosuppressive therapy in patients with connective tissue disease‐associated pulmonary arterial hypertension: A systematic review. International Journal of Rheumatic Diseases. 25(9). 982–990. 11 indexed citations
15.
Zhao, Jiuliang, Junyan Qian, Li Zhang, et al.. (2022). The role of anti-ribosomal P autoantibodies in the prediction of neuropsychiatric damage in systemic lupus erythematosus based on CSTAR cohort (XIV). Clinical Rheumatology. 41(5). 1371–1379. 3 indexed citations
16.
Hu, Chaojun, Mengtao Li, Jian Liu, et al.. (2017). Anti-SmD1 antibodies are associated with renal disorder, seizures, and pulmonary arterial hypertension in Chinese patients with active SLE. Scientific Reports. 7(1). 7617–7617. 11 indexed citations
17.
Qian, Junyan, Yanhong Wang, Can Huang, et al.. (2015). Survival and prognostic factors of systemic lupus erythematosus-associated pulmonary arterial hypertension: A PRISMA-compliant systematic review and meta-analysis. Autoimmunity Reviews. 15(3). 250–257. 40 indexed citations
18.
Qian, Junyan. (2015). Cholestasis, ascites and pancytopenia in an immunocompetent adult with severe cytomegalovirus hepatitis. World Journal of Gastroenterology. 21(43). 12505–12505. 6 indexed citations
19.
Zheng, Yuhuan, Jing Yang, Junyan Qian, et al.. (2012). PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma. Leukemia. 27(3). 702–710. 125 indexed citations
20.
Yang, Jing, Jin He, Yabing Cao, et al.. (2012). Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma. Leukemia. 26(9). 2114–2123. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026